Cargando…
COVID-19 Vaccine Effectiveness in Oncology Patients
Oncology patients are at greater risk of morbidity and mortality from coronavirus disease 2019 (COVID-19) infection than the general population. Patients with malignancies were prioritized in vaccine distribution to confer protection to a vulnerable population. However, immunocompromised patients we...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214963/ https://www.ncbi.nlm.nih.gov/pubmed/35755900 http://dx.doi.org/10.6004/jadpro.2022.13.4.6 |